Malta David Braga

Chief Executive Officer at LiMM Therapeutics SA

Consumer Services

Health Technology

Finance

Profile

Malta David Braga was the founder of Cell2B - Advanced Therapeutics SA, where he held the titles of President, Chief Executive Officer & Director.
The company was founded in 2011.
Dr. Braga is also the founder of LiMM Therapeutics SA. He graduated from Instituto Superior Técnico de Lisboa and earned a doctorate degree from Massachusetts Institute of Technology Portugal.

Malta David Braga active positions

Companies	Position	Start
LiMM Therapeutics SA LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France.	Chief Executive Officer	-

All active positions of Malta David Braga

Former positions of Malta David Braga

Companies	Position	End
Cell2B - Advanced Therapeutics SA Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal.	Chief Executive Officer	-

See the detail of Malta David Braga's experience

Training of Malta David Braga

Instituto Superior Técnico de Lisboa	Graduate Degree
Massachusetts Institute of Technology Portugal	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Malta David Braga's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Cell2B - Advanced Therapeutics SA Cell2B - Advanced Therapeutics SA BiotechnologyHealth Technology Cell2B - Advanced Therapeutics SA engages in the development of stem cell therapies for immune and inflammatory diseases. Its pipeline consists of cord blood unit expansion and anti-rejection medications. The company was founded by Daniela Couto, David Braga Malta, Francisco dos Santos, and Pedro Andrade in 2011 and is headquartered in Cantanhede, Portugal.	Health Technology
LiMM Therapeutics SA LiMM Therapeutics SA Financial ConglomeratesFinance LiMM Therapeutics SA operates as a biopharmaceutical corporation, that specializes in molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. The firm develops medicines against inflammatory, infectious, and metabolic diseases. The company was founded by David Braga Malta and Henrique Veiga Fernandes and is headquartered in Paris, France.	Finance